Lettmann Jason

ALX Oncology Holdings Inc. · CHIEF EXECUTIVE OFFICER

Lettmann Jason is listed in public filings as director, officer: CHIEF EXECUTIVE OFFICER. This Lettmann Jason insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include ALX Oncology Holdings Inc. (ALXO). Investors use Lettmann Jason's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

History Trades

CompanyValueActionPriceCurrent Price
ALX Oncology Holdings Inc.ALXO$77k71.2k sharesBuySep 17, 2025$1.08--
ALX Oncology Holdings Inc.ALXO$22k21.1k sharesBuySep 16, 2025$1.07--
ALX Oncology Holdings Inc.ALXO$1.5k2.4k sharesSellAug 15, 2025$0.6404--
ALX Oncology Holdings Inc.ALXO$2.5k2.2k sharesSellFeb 19, 2025$1.15--
Lettmann Jason History Trades | 交易笔记